GX1
GENXONE
NEWCONNECT
LISTED
source: current reports (ESPI/EBI) · incomplete data — not every contract is disclosed · 8 contracts in the database
DISCLOSED VALUE 12M
Sum of the value of contracts from the last 12 months where the company disclosed an amount; contracts with no disclosed value are excluded.
2.7 m PLN
4 of 5 contracts
+1 in another currency, excluded from the total
SHARE OF REVENUE 12M
Disclosed contract value relative to the company's revenue; computed only when both figures are in PLN.
—
no revenue data in the database
LARGEST COUNTERPARTY
87.4%
Human Biome S.A.
LONGEST TERM
1 year
until 2027
No contracts in this category.
The registry is built from significant-contract announcements — none of this company's contracts carries the selected status.
Counterparty concentration
share of disclosed contract value over the last 12 months
Human Biome S.A.
87.4%
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji
9.1%
Warszawski Uniwersytet Medyczny
3.5%
Portfolio summary
Contracts
8
Active
8
Total value
4.2 m PLN
Average value
603 k PLN
Since
March 01, 2026
Where this data comes from
Contracts come from current reports (ESPI/EBI) — the company discloses only those exceeding its materiality threshold. The list is by definition incomplete.
Status — inferred from the event type and the term's end date, not a dedicated source field.
Share of revenue 12M — only when both the contracts' dominant currency and the company's reporting currency are PLN, with no currency conversion.